Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome

PURPOSE: Antitumor activity of cancer immunotherapies may elicit immune responses to nontargeted (secondary) tumor antigens, or antigen spread. We evaluated humoral antigen spread after treatment with sipuleucel-T, an immunotherapy for asymptomatic or minimally symptomatic metastatic castration-resi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cancer Res
Glavni autori: GuhaThakurta, Debraj, Sheikh, Nadeem A., Fan, Li-Qun, Kandadi, Harini, Meagher, T. Craig, Hall, Simon J., Kantoff, Philip W., Higano, Celestia S., Small, Eric J., Gardner, Thomas A., Bailey, Kate, Vu, Tuyen, DeVries, Todd, Whitmore, James B., Frohlich, Mark W., Trager, James B., Drake, Charles G.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868054/
https://ncbi.nlm.nih.gov/pubmed/25649018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2334
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items